15 July 2014

Egypt Signs Deal With U.S.'s Gilead to Provide "Virus C" Cure for 1 Percent of Price

Cairo — Egyptian Prime Minister Ibrahim Mehleb and Health Minister Adel al-Adawy have signed an agreement with the U.S.'s Gilead company to sell its Sovaldi treatment for curing Hepatitis C to Egyptians for 1% of its price.

Those with health insurance and/or being treated at state expenses will be able to buy the cure at 2,200 Egyptian pounds as opposed to its real price of 200,000 pounds (28,000 US Dollar).

In a press conference on Tuesday, Adawy said that the cure will be available in the last week of September at 26 national centers for treating liver diseases and Virus C in particular.

"This is a historic day for Egypt and patients with liver diseases," the minister said at the conference, adding that abroad the treatment, which lasts 3 months, costs about 84,000 US Dollar.

He added that some 170 shots will be provided until the end of December and up to 225,000 shots by February next year.

Egypt has one of the highest rates of Virus C in the world.

Copyright © 2014 Aswat Masriya. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 2,000 reports a day from more than 130 news organizations and over 200 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.